All AbMole products are for research use only, cannot be used for human consumption.
Nebivolol hydrochloride is a β1 receptor blocker with an IC50 of 4.5 µM. It has nitric oxide-potentiating vasodilatory effect used in treatment of hypertension. Nebivolol was compared with DETA-NO and S-nitroso-N-acetylpenicillamine (SNAP), two nitric oxide (NO) donor agents, and alpha-difluoromethylornithine (DFMO), a known inhibitor of ornithine decarboxylase (ODC). All four test agents inhibited RASMC proliferation in a concentration-dependent manner, with nebivolol being the most potent (IC (50) = 4.5 microM), whereas atenolol, another relatively selective beta (1)-blocker, was inactive.
| Cell Experiment | |
|---|---|
| Cell lines | Human coronary smooth muscle cells (haCSMCs) and endothelial cells (haECs) |
| Preparation method | Exposing cells to different concentrations of Nebivolol (10-7~10-5 M) for 1, 2, 4, 7 and 14 days. Using bromodeoxyuridine (BrdU) incorporation to analyze cell proliferation , and PI or annexin V staining to detect cell apoptosis . |
| Concentrations | Dissolved in 100% methanol and diluted with three volumes of growth medium to obtain a stock solution of 10-3 M, final concentration 10-7~10-5 M |
| Incubation time | 1, 2, 4, 7 and 14 days |
| Animal Experiment | |
|---|---|
| Animal models | Male Sprague Dawley rat myocardial infarction (MI) model |
| Formulation | Dissolved in DMSO and diluted in saline |
| Dosages | 2.0 mg/kg |
| Administration | Gastric gavage once daily |
| Molecular Weight | 441.9 |
| Formula | C22H25F2NO4.HCl |
| CAS Number | 152520-56-4 |
| Solubility (25°C) | DMSO 80 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Sarah J Wang, et al. Nebivolol/valsartan combination for the treatment of hypertension: a review
[2] Nasima Olawi, et al. Nebivolol in the treatment of arterial hypertension
[3] Dawn Battise, et al. Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination Tablet
| Related Adrenergic Receptor Products |
|---|
| Tamsulosin hydrochloride
Tamsulosin is a new, highly selective α1A-adrenoceptor antagonist. |
| Mirabegron
Mirabegron (YM178) is a potent and selective β(3)-adrenoceptor agonist with EC50 of 22.4 nM. |
| Detomidine hydrochloride
Detomidine hydrochloride is a nonnarcotic, synthetic alpha-2 adrenoreceptor agonist. |
| (R)-(+)-Atenolol
(R)-(+)-Atenolol binds to but does not activate beta-adrenergic receptors thereby blocking the actions of endogenous or exogenous beta-adrenergic agonists. |
| Reboxetine mesylate
Reboxetine mesylate is a potent and selective inhibitor of noradrenalin uptake (Ki values are 1.1, 129 and > 10000 nM for rat NET, SERT and DAT respectively). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
